CBIO vs XPO · rev $1.0M vs P/E 69, rev $2.35B
Crescent Biopharma, Inc. (CBIO) versus XPO Logistics Inc (XPO) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
XPO Logistics Inc (XPO) is a trucking company listed on NYSE.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Latest reported XPO revenue for 2026-06-30 was $2.35B. Net income was $162.0M. Revenue was up 12.4% from 2026-03-31 to 2026-06-30. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
CBIO currently screens at market cap $491.3M. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
Not investment advice. Open the CBIO and XPO stock pages for the full models.
Not investment advice.